Oncology

Latest News

CureCancer | Image Credit: © MMPhoto21-sotck.adobe.com

COA 2025: Insight, Innovation, and Independent Strength

By Maggie L. Shaw

May 5th 2025

The 2025 Community Oncology Conference empowered attendees with insights on advocacy, innovation, and practical strategies for enhancing community cancer care.

Community Oncology Reacts to Trump's Drug Pricing Executive Order

By Maggie L. Shaw

May 2nd 2025

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com

5 Things You Should Know About Skin Cancer

By Pearl Steinzor

May 2nd 2025

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com

Patient Navigation Is Nonnegotiable in Cancer Care

By Maggie L. Shaw

May 1st 2025

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg

Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

By AJMC Contributor

May 1st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

November 24th 2014

The Road to Extinction: Oncology Private Practice

This article in The New York Times details the reasons why private oncology practices are being forced to consolidate to stay afloat.

November 24th 2014

Northwestern Study Discovers Treatment For Pediatric Gliomas

The study, published in Nature Medicine, identified a small molecule inhibitor that increases histone methylation, compensating for the reduced methylation caused by mutation in the H3F3A gene, resulting in gliomas.

November 23rd 2014

Preclinical Model to Guide Immunotherapeutic Development

Champions Oncology will be presenting data on it's preclinical model at the ongoing EORTC-NCI-AACR Symposium in Barcelona. The model proposes to help develop individualized treatments for patients.

November 22nd 2014

MSKCC Research Provides Lead On Immuno-oncology Resistance

Scientists at the Memorial Sloan Kettering Cancer Center have identified that tumor mutation burden could help predict responders to ipilimumab treatment. The report has been published online in the New England Journal of Medicine.

November 21st 2014

Active Surveillance Might Work for Most With Prostate Cancer

A recent study published in European Urology highlights quality-of-life benefits with active surveillance in men with prostate cancer.

November 21st 2014

Generic Drug Price Escalation Debate Reaches the Senate

Vermont Senator Bernie Sanders has introduced a bill that would require generic drugmakers to pay rebates to the federal Medicare and Medicaid programs when prices of their medications outpace inflation.

November 21st 2014

Salk Scientists Want to Target the Protein Interactome for Drug Discovery

The study, published in Cell Reports, evaluates the dynamic protein interactions that promote different diseases including cancer. By capturing these interactions, the authors hope to discover new drug targets.

November 20th 2014

Large National Study Identifies Mastectomy Trend in Early Stage Disease

The retrospective study, published in JAMA Surgery, could not necessarily point to the underlying reason for this treatment choice.

November 20th 2014

IMS Report Estimates Over A Trillion Dollars in Drug Spending This Year

According to the report, sofosbuvir for hepatitis C infections and new cancer drugs were the drivers of the high spending costs, a 7% jump over the previous year.

November 19th 2014

The Argument For Better Patient-Centered Care in Oncology

Laura Joszt, MA

After 4 years of living with inflammatory breast cancer, Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, she still felt fine, which she attributed to her care choices, she explained during her speech at The American Journal of Managed Care's Patient-Centered Oncology Care meeting in Baltimore, Maryland.

November 18th 2014

Study Identifies Disparities in Lung Cancer Treatment

The study, published in the Journal of Thoracic Oncology, identified race, insurance status, and the treatment center as variables that influenced treatment received by individuals with early-stage lung cancer.

November 18th 2014

ASCO Members Take a Stand on Access to Care for Low-Income Individuals

Surabhi Dangi-Garimella, PhD

In a paper published in the Journal of Clinical Oncology, medical oncologists have delineated their recommendations to improve cancer care and provide better access to quality care for those patients with financial issues and on Medicaid.

Dr Howard K. Kaufman Explains the Importance of Diagnostics on Precision Medicine

November 17th 2014

Dr Howard K. Kaufman Explains the Importance of Diagnostics on Precision Medicine

The evolving field of precision medicine is very much reliant on diagnostics, Howard K. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, said at The American Journal of Managed Care's Patient-Centered Oncology Care meeting.

November 17th 2014

AJMC's Oncology Stakeholder Summit Participants Discuss Stringencies of Data Generation and Analysis

Surabhi Dangi-Garimella, PhD

November 17th 2014

Overuse of Imaging Adds $500 Million in Healthcare Costs, 500 More Cancer Cases a Year, Study Finds

Mary K. Caffrey

November 17th 2014

Tumor Treating Fields Can Halt Glioblastomas

An electrical device glued to the scalp can slow cancer growth and prolong survival in people with the deadliest type of brain tumor, researchers reported on Saturday in Miami, at a meeting of the Society for Neuro-Oncology.

November 17th 2014

Merck's Immuno-Oncology Molecule to Be Supported by Pfizer

The collaboration between the 2 drug giants will prove a big boost to Merck's cancer immunotherapy MSB0010718C, and will also improve it's global oncology business.

November 17th 2014

After Delays, Reimbursement Approvals Seen for Diagnostic Tests

Mary K. Caffrey

November 17th 2014

AJMC Panel Explores Immuno-oncology, and What Making Cancer a Chronic Condition Means for Payers

Mary K. Caffrey

November 17th 2014

Fertility Preservation in Young Cancer Patients

Surabhi Dangi-Garimella, PhD

November 17th 2014

Merck's Pembrolizumab: Breakthrough in NSCLC

Surabhi Dangi-Garimella, PhD

November 17th 2014

Panel Members Discuss Data Quality in Oncology Care

Surabhi Dangi-Garimella, PhD

November 17th 2014

The Challenge of Developing the Ideal Patient Satisfaction Survey

Betsy Chase Steven Dâ€™Amato, BSPharm, BCOP

November 17th 2014

The Debate on Treatment Options in Early-Stage Breast Cancer

Surabhi Dangi-Garimella, PhD

November 17th 2014

AJMC Oncology Conference Helps Managed Care Stakeholders Do More for Patients Who Have Coverage, But Still Have Limits

At its third annual conference, Patient-Centered Oncology Care 2014, The American Journal of Managed Care addressed new challenges in cancer care: more patients have coverage, but they may be "underinsured" or barred from academic centers. Amid rising drug costs and regulations that threaten community practices, the head of the largest oncology organization outlined a path toward value-based reimbursement.

November 17th 2014

Nivolumab Presents Superior Survival Results in Phase 3 Melanoma Trials

In a press release based off-of results presented at the Society for Melanoma Research 2014 International Congress in Zurich, Switzerland, BMS announced results from phase 3 of the CheckMate-066 trial.

November 16th 2014

A New Glioblastoma Vaccine on the Horizon

Following encouraging results from a second phase of a phase 1 trial, the researchers have planned a second phase, to be initiated in January 2015. The vaccine will be administered to glioblastoma patients just before they begin chemotherapy.

November 16th 2014

Long-term Results of Vismodegib in Patients With Basal Cell Carcinoma Reported

Final safety and efficacy results for vismodegib were reported at the Society for Melanoma Research, 2014 International Congress, for the 30-month mark of the ERIVANCE trial. The Congress is meeting November 13-16 in Zurich, Switzerland.

November 16th 2014

Oncolytic Virus Proves Promising in Advanced Melanoma

Despite the various treatment advances in melanoma, advanced stages of the disease remain a significant challenge for oncologists. Novel methods of attacking disease vulnerabilities continue to be developed-one such technique is the use of oncolytic viruses to destroy cancer cells. A couple of studies presented an update on preclinical and clinical progress with CAVATAK, formulated using the common cold Coxsackievirus Type A21 (CVA21), during the Society for Melanoma Research, 2014 International Congress in Zurich, Switzerland, November 13—16.

November 16th 2014

Vemurafenib Treatment Beyond Progression Is Safe and Highly Effective in Patients with Metastatic Melanoma

Patients with metastatic melanoma receiving vemurafenib following disease progression showed similar or better overall response to patients without progressive disease, according to findings from an analysis reported at the 11th International Congress of the Society for Melanoma Research on November 15, 2014.

...

145 146 147 148 149 150 151 152 153

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions